期刊文献+

阿片类药物防滥用药学技术研究进展

Advances in studies on opioids with abuse-deterrent formulations
下载PDF
导出
摘要 阿片类药物在治疗中重度疼痛的药物中占有重要地位,但在其应用过程中出现了大量药品滥用与成瘾的现象,引发了严重的社会问题。美国作为药品滥用程度最严重的国家之一,2011年前后,FDA先后发布了一系列有关阿片类药物开发的指导原则和评价通则,加快并促进了药品防滥用方面技术的革新。本文根据《Abuse-Deterrent Opioids—Evaluation and Labeling Guidance for Industry》中提出的几种药品防滥用技术对近年来国外各种阿片类上市药物进行分析,期望对国内相关领域的研究提供帮助。 Opioids have played an important role in the treatment of moderate and severe pain.But a large number of drug abuse and addiction have emerged in their application,which has caused serious social problems.The United States is one of the countries with the most serious drug abuse.Around 2011,FDA successively issued a series of guidelines and evaluation rules on the development of opioids,speeding up and promoting the innovation of drug abuse prevention technology.We analyzes various opioids on the market abroad in recent years according to several drug abuse prevention technologies proposed in the"Abuse-Deterrent Opioids—Evaluation and Labeling Guidance for Industry".It is expected to be helpful to domestic research in related fields.
作者 丁嘉信 王艳莉 王萌 薛云丽 DING Jiaxin;WANG Yanli;WANG Meng;XUE Yunli(Shandong Luye Pharmaceutical Co.,Ltd.,Yantai 264003,China;Yantai Science and Technology Innovation Promotion Center,Yantai 264003,China)
出处 《药学研究》 CAS 2024年第2期178-183,共6页 Journal of Pharmaceutical Research
基金 泰山产业领军人才工程支持项目 烟台市省级以上领军人才专项配套经费资助。
关键词 阿片类药物 防滥用技术 聚氧乙烯 拮抗剂 厌恶剂 Opioids Abuse-deterrent PEO Antagonist Aversion
  • 相关文献

参考文献6

二级参考文献39

  • 1李菊梅.聚氧化乙烯合成工艺研究[J].石化技术与应用,2008,26(2):128-130. 被引量:4
  • 2武林鑫,孙莉.癌痛治疗不足的现状与原因[J].肿瘤防治研究,2014,41(4):421-424. 被引量:78
  • 3张治国,尹红.环氧乙烷和环氧丙烷开环聚合[J].化学进展,2007,19(1):145-152. 被引量:24
  • 4朱正勇,曾飞聆.盐酸羟考酮新剂型——奥施康定~[J].海峡药学,2007,19(7):82-83. 被引量:21
  • 5杨琦.聚环氧乙烷的合成及催化剂体系[J].石化技术,2007,14(3):44-48. 被引量:5
  • 6Jennifer S. Orman,Gillian M. Keating.Buprenorphine/Naloxone[J]. Drugs . 2009 (5)
  • 7Mark Palangio,Donald W Northfelt,Russell K Portenoy,Daniel Brookoff,Ralph T Doyle,Bruce E Dornseif,Michael C Damask.Dose Conversion and Titration with a Novel, Once-Daily, OROS ? Osmotic Technology, Extended-Release Hydromorphone Formulation in the Treatment of Chronic Malignant or Nonmalignant Pain[J]. Journal of Pain and Symptom Management . 2002 (5)
  • 8Lynn R Webster,Brad Bath,Robert A Medve.Opioid formulations in development designed to curtail abuse: who is the target?. Expert Opinion on Investigational Drugs . 2009
  • 9Helm Standiford,Trescot Andrea M,Colson James,Sehgal Nalini,Silverman Sanford.Opioid antagonists, partial agonists, and agonists/antagonists: the role of office-based detoxification. Pain physician . 2008
  • 10Katz Nathaniel P,Adams Edgar H,Chilcoat Howard,Colucci Robert D,Comer Sandra D,Goliber Philip,Grudzinskas Charles,Jasinski Donald,Lande Stephen D,Passik Steven D,Schnoll Sidney H,Sellers Edward,Travers Debra,Weiss Roger.Challenges in the development of prescription opioid abuse-deterrent formulations. The Clinical Journal of Pain . 2007

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部